Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4359360 | 0.97 | FFAR3 (0.31) | FFAR3 | |
| Hydrochloric Acid SCHEMBL2198959 | 0.97 | FFAR3 (0.31) | FFAR3 | |
| SCHEMBL4589011 | 0.92 | CYP2C19 (0.33) | FFAR3CYP2C19 | |
| SCHEMBL741463 | 0.86 | — | — | |
| SCHEMBL7387847 | 0.81 | NPSR1 (0.37) | — | |
| SCHEMBL2489958 | 0.80 | FFAR3 (0.36) | FFAR3 | |
| SCHEMBL28863673 | 0.77 | — | — | |
| SCHEMBL628215 | 0.77 | — | — | |
| SCHEMBL2772996 | 0.74 | FFAR3 (0.32) | FFAR3CYP2C19 | |
| SCHEMBL15571664 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727514-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | The Procter & Gamble Company (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4619244-A1 | COMPOSITION FOR PRODUCING A POLYMER, USE OF THE COMPOSITION FOR PRODUCING A POLYMER, AND POLYMER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-09-24 | — | — | EP | claimed |
| CN-120059154-A | In C4Method for producing polybutylene succinate polyester by taking unsaturated binary oxygen-containing compound as raw material | 上海师范大学 | 2025-05-30 | — | — | CN | claimed |
| WO-2024259180-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2024-12-19 | — | — | WO | claimed |
| US-20240415753-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY | 2024-12-19 | — | — | US | claimed |
| US-12024496-B2 | Conversion of 1,2,5,6-hexanetetrol (HTO) to tetrahydrofuran dicarboxylic acid (THFDCA) | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2024-07-02 | — | — | US | claimed |
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| CN-118184605-A | Method for preparing tetrahydrofuran dicarboxylic acid by oxidizing tetrahydrofuran dimethanol | 中国科学院宁波材料技术与工程研究所 | 2024-06-14 | — | — | CN | claimed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | claimed |
| WO-2024104982-A1 | COMPOSITION FOR PRODUCING A POLYMER, USE OF THE COMPOSITION FOR PRODUCING A POLYMER, AND POLYMER | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-05-23 | — | — | WO | claimed |
| US-8969404-B2 | Purifying crude furan 2,5-dicarboxylic acid by hydrogenation | EASTMAN CHEMICAL COMPANY (US) | 2015-03-03 | — | — | US | claimed |
| US-20140364633-A1 | PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION | EASTMAN CHEMICAL COMPANY (US) | 2014-12-11 | — | — | US | claimed |
| US-20140311507-A1 | Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| US-8748479-B2 | Process for purifying crude furan 2,5-dicarboxylic acid using hydrogenation | EASTMAN CHEMICAL COMPANY (US) | 2014-06-10 | — | — | US | claimed |
| WO-2013191944-A1 | PROCESS FOR PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID USING HYDROGENATION | EASTMAN CHEMICAL COMPANY (US) | 2013-12-27 | — | — | WO | claimed |
| WO-2013191943-A1 | PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION | EASTMAN CHEMICAL COMPANY (US) | 2013-12-27 | — | — | WO | claimed |
| US-20130345451-A1 | PROCESS FOR PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID USING HYDROGENATION | EASTMAN CHEMICAL COMPANY (US) | 2013-12-26 | — | — | US | claimed |
| US-20130345452-A1 | PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION | EASTMAN CHEMICAL COMPANY (US) | 2013-12-26 | — | — | US | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130345451-A1 | PROCESS FOR PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID USING HYDROGENATION | HPD, HAO2, HAAO | FFAR3 506/4885CYP2C19 706/4885 |
| US-20140364633-A1 | PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION | PCCA, DDC, MCCC2 | FFAR3 621/4885CYP2C19 970/4885 |
| US-20240415753-A1 | DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS | ALOX5, DRD5, LBR | FFAR3 38/4885CYP2C19 1575/4885 |
| US-20130345452-A1 | PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION | PCCA, DDC, MCCC2 | FFAR3 621/4885CYP2C19 970/4885 |
| US-12024496-B2 | Conversion of 1,2,5,6-hexanetetrol (HTO) to tetrahydrofuran dicarboxylic acid (THFDCA) | DHODH, MTHFD2, DPYD | FFAR3 2665/4885CYP2C19 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.